Inovio Pharmaceuticals Inc. closed $12.82 below its 52-week high ($14.75), which the company achieved on April 1st.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

26.79% of the stock is owned by institutional investors. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever INO has been the ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more ...

The stock has gained ground following similar conference events recently. Positive coverage from Wedbush analyst Daniel Ives has added to the stock's bullish momentum. The stock is gaining ground ...